(Q50737610)

18 March 2018

title

Acute effects of ayahuasca on neuropsychological performance: differences in executive function between experienced and occasional users. (English)

1 reference

18 March 2018

1 reference

1 reference

Jordi Riba

5

0 references

Rosa Maria Antonijoan

3

object named as

Rosa Maria Antonijoan

1 reference

18 March 2018

author name string

José Carlos Bouso

1

1 reference

18 March 2018

Josep Maria Fábregas

2

1 reference

18 March 2018

Antoni Rodríguez-Fornells

4

1 reference

18 March 2018

publication date

21 June 2013

1 reference

18 March 2018

number of pages

10

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

18 March 2018

volume

230

1 reference

18 March 2018

issue

3

1 reference

18 March 2018

page(s)

415-424

1 reference

18 March 2018

https://scigraph.springernature.com/pub.10.1007/s00213-013-3167-9

exact match

0 references

cites work

Functional MRI evidence for inefficient attentional control in adolescent chronic cannabis abuse

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3167-9

Serotonin induces excitatory postsynaptic potentials in apical dendrites of neocortical pyramidal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3167-9

Mechanism of the 5-hydroxytryptamine 2A receptor-mediated facilitation of synaptic activity in prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3167-9

Personality, psychopathology, life attitudes and neuropsychological performance among ritual users of Ayahuasca: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3167-9

BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3167-9

Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3167-9

Anterior cingulate cortex and conflict detection: an update of theory and data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3167-9

Psilocybin impairs high-level but not low-level motion perception

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3167-9

Using psilocybin to investigate the relationship between attention, working memory, and the serotonin 1A and 2A receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3167-9

Modulating the rate and rhythmicity of perceptual rivalry alternations with the mixed 5-HT2A and 5-HT1A agonist psilocybin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3167-9

Psilocybin links binocular rivalry switch rate to attention and subjective arousal levels in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3167-9

Pharmacological modulation of the neural basis underlying inhibition of return (IOR) in the human 5-HT2A agonist and NMDA antagonist model of psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3167-9

Neuronal correlates of visual and auditory alertness in the DMT and ketamine model of psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3167-9

Quantitative analysis of glutamatergic and GABAergic neurons expressing 5-HT(2A) receptors in human and monkey prefrontal cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3167-9

Prefrontal cortical contributions to working memory: evidence from event-related fMRI studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3167-9

Estimation of premorbid intelligence in Spanish people with the Word Accentuation Test and its application to the diagnosis of dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3167-9

Enhancement of planning ability by transcranial direct current stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3167-9

Autonomic, neuroendocrine, and immunological effects of ayahuasca: a comparative study with d-amphetamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3167-9

The hallucinogen d-lysergic acid diethylamide (d-LSD) induces the immediate-early gene c-Fos in rat forebrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3167-9

Effects of ayahuasca on binocular rivalry with dichoptic stimulus alternation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3167-9

Serotonin research: contributions to understanding psychoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3167-9

Modulation of DOI-induced increases in cortical BDNF expression by group II mGlu receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3167-9

Psychedelics and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3167-9

Agonist-trafficking and hallucinogens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3167-9

Neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers. A double-blind, placebo-controlled PET study with [18F]FDG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3167-9

Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d-methamphetamine in healthy volunteers. Results of an experimental double-blind placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3167-9

Effects of the hallucinogen psilocybin on covert orienting of visual attention in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3167-9

Inhibition of return in the human 5HT2A agonist and NMDA antagonist model of psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3167-9

Lysergic acid diethylamide-induced Fos expression in rat brain: role of serotonin-2A receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3167-9

Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3167-9

Molecular biology of 5-HT receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3167-9

Functional connectivity in brain networks underlying cognitive control in chronic cannabis users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3167-9

Effects of acute smoked marijuana on complex cognitive performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3167-9

Neurophysiological and cognitive effects of smoked marijuana in frequent users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3167-9

Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose?effect study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3167-9

Mismatch negativity generation in the human 5HT2A agonist and NMDA antagonist model of psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3167-9

Mescaline-induced psychopathological, neuropsychological, and neurometabolic effects in normal subjects: experimental psychosis as a tool for psychiatric research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3167-9

Neuropharmacology of performance monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3167-9

Modality specific cerebro-cerebellar activations in verbal working memory: an fMRI study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3167-9

Group II mGlu receptor agonists inhibit behavioural and electrophysiological effects of DOI in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3167-9

An integrative theory of prefrontal cortex function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3167-9

Dementia: the estimation of premorbid intelligence levels using the New Adult Reading Test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3167-9

Subjective effects and tolerability of the South American psychoactive beverage Ayahuasca in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3167-9

Topographic pharmaco-EEG mapping of the effects of the South American psychoactive beverage ayahuasca in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3167-9

Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3167-9

Increased frontal and paralimbic activation following ayahuasca, the pan-Amazonian inebriant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3167-9

The neuropsychopharmacology of fronto-executive function: monoaminergic modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3167-9

Functional brain maps of Tower of London performance: a positron emission tomography and functional magnetic resonance imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3167-9

Specific impairments of planning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3167-9

Brain-derived neurotrophic factor and control of synaptic consolidation in the adult brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3167-9

Increased activation of indirect semantic associations under psilocybin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3167-9

High-Speed Scanning in Human Memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3167-9

Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3167-9

Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3167-9

Functional MRI of inhibitory processing in abstinent adolescent marijuana users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3167-9

Effects of the 5-HT2A agonist psilocybin on mismatch negativity generation and AX-continuous performance task: implications for the neuropharmacology of cognitive deficits in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3167-9

The neurobiology of psychedelic drugs: implications for the treatment of mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3167-9

Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3167-9

Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3167-9

The effects of the preferential 5-HT2A agonist psilocybin on prepulse inhibition of startle in healthy human volunteers depend on interstimulus interval

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3167-9

Effects of varied doses of psilocybin on time interval reproduction in human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3167-9

Effects of psilocybin on time perception and temporal control of behaviour in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3167-9

The physiological role of 5-HT2A receptors in working memory

21 January 2018

1 reference

12 December 2020

The 5-HT2A/1A Agonist Psilocybin Disrupts Modal Object Completion Associated with Visual Hallucinations

1 reference

12 December 2020

Double dissociation of serotonergic and dopaminergic mechanisms on attentional performance using a rodent five-choice reaction time task

1 reference

12 December 2020

Pharmacology of ayahuasca administered in two repeated doses

1 reference

12 December 2020

Prefrontal executive function and D1, D3, 5-HT2A and 5-HT6 receptor gene variations in healthy adults

1 reference

12 December 2020

Hallucinogenic drug induced states resemble acute endogenous psychoses: results of an empirical study

1 reference

12 December 2020

5-HT2A receptor-mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex.

1 reference

12 December 2020

Functional connectivity measures after psilocybin inform a novel hypothesis of early psychosis

1 reference

12 December 2020

Effects of the hallucinogen psilocybin on habituation and prepulse inhibition of the startle reflex in humans.

1 reference

12 December 2020

Visualizing brain activation during planning: the tower of London test adapted for functional MR imaging

1 reference

12 December 2020

10.1007/S00213-013-3167-9

Identifiers

DOI

1 reference

18 March 2018

PubMed ID

23793226

1 reference

18 March 2018